Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

INO - Inovio Pharmaceuticals Inc


IEX Last Trade
7.21
-0.110   -1.526%

Share volume: 207,284
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$7.32
-0.11
-1.50%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31
Fiscal Quarter Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024
Report Date 2022-08-09 2022-11-08 2023-03-01 2023-05-10 2023-08-09 2023-11-09 2024-03-06 2024-05-13
Total revenue 784.395 K 9.154 M 124.666 K 114.943 K 225.971 K 388.446 K 102.650 K 0.000
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 784.395 K 9.154 M 124.666 K 114.943 K 225.971 K 388.446 K 102.650 K 0.000
    1,067.03% -98.64% -7.80% 96.59% 71.90% -73.57% -100.00%  
Operating expenses 104.922 M 44.911 M 56.071 M 44.067 M 37.267 M 25.428 M 27.496 M 31.485 M
Selling general and admin 48.457 M 11.824 M 13.951 M 13.891 M 13.523 M 9.925 M 10.243 M 10.571 M
Research and development 56.465 M 33.087 M 42.120 M 30.177 M 23.744 M 15.503 M 17.253 M 20.914 M
Total expenses 105.856 M 45.216 M 56.194 M 44.067 M 37.267 M 25.428 M 26.723 M 31.611 M
    -57.29% 24.28% -21.58% -15.43% -31.77% 5.09% 18.29%  
Operating income -105.071 M -36.062 M -56.069 M -43.952 M -37.041 M -25.040 M -26.621 M -31.611 M
Ebit -105.071 M -36.062 M -58.234 M -43.336 M -36.884 M -24.825 M -27.608 M -31.611 M
Pretax income -108.497 M -37.784 M -56.628 M -40.649 M -35.535 M -33.930 M -25.004 M -30.470 M
    -65.18% 49.87% -28.22% -12.58% -4.52% -26.31% 21.86%  
Income tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Net income basic -108.497 M -37.784 M -54.463 M -40.649 M -35.535 M -33.930 M -25.004 M -30.470 M
    65.18% -44.14% 25.36% 12.58% 4.52% 26.31% -21.86%  
Net income -108.497 M -37.784 M -54.463 M -40.649 M -35.535 M -33.930 M -25.004 M -30.470 M
    65.18% -44.14% 25.36% 12.58% 4.52% 26.31% -21.86%